丁苯酞联合颈动脉支架置入术对急性缺血性卒中患者血管再通的研究及术后再狭窄的观察

曹灿; 杨建豪; 王睿琪; 程光森; 刘羽; 李忠亮; 李晓芬; 方秦; 罗玉鸿; 宋梦姣

doi:10.15912/j.issn.1671-8194.2025.12.002

PDF(667 KB)

中国医药指南 ›› 2025, Vol. 23 ›› Issue (12) : 6-9. DOI: 10.15912/j.issn.1671-8194.2025.12.002

论著

丁苯酞联合颈动脉支架置入术对急性缺血性卒中患者血管再通的研究及术后再狭窄的观察

曹灿¹, 杨建豪², 王睿琪³, 程光森², 刘羽², 李忠亮², 李晓芬³, 方秦⁴, 罗玉鸿^3,*, 宋梦姣^3,*

作者信息 +

The Study of Vascular Recanalization and the Observation of Postoperative Restenosis in Patients with Acute Ischemic Stroke by Butylphthalide Combined with Carotid Artery Stenting

CAO Can¹, YANG Jianhao², WANG Ruiqi³, CHENG Guangsen², LIU Yu², LI Zhongliang², LI Xiaofen³, FANG Qin⁴, LUO Yuhong^3,*, SONG Mengjiao^3,*

Author information +

摘要

目的探讨丁苯酞联合颈动脉支架置入术对急性缺血性卒中患者血管再通的影响及对术后再狭窄的观察。方法回顾性纳入2021年1月至2022年12月珠海市人民医院41例急性缺血性卒中患者,分为对照组（21例）和观察组（20例）,对照组采用颈动脉支架置入术和常规治疗,观察组在对照组的基础上,于术前开始给予丁苯酞氯化钠注射液治疗,采用改良脑梗死溶栓（mTICI）分级评价血管再通情况,术后mTICI分级达到2b或3级则表示血管再通成功,其中3级表示血管完全再通,比较两组患者术后的mTICI分级情况。统计两组患者术后3~6个月以颈动脉彩超或脑血管造影的方式复查发现术后再狭窄的例数。结果对照组术后mTICI分级为3级21例,观察组术后mTICI分级为2b级1例和3级19例,两组患者均实现术后血管再通成功,但是两组之间的差异无统计学意义（P>0.05）。两组患者CAS术后3~6个月返院复查共计22例,术后再狭窄的例数分别为对照组3例（23.08%）、观察组1例（11.11%）,两组之间的差异无统计学意义（P>0.05）。结论颈动脉支架置入术前开始给予丁苯酞治疗,其对急性缺血性卒中患者血管再通情况（mTICI分级）和术后远期再狭窄未见明显影响。

Abstract

Objective To investigate the effect of butylphthalide combined with carotid artery stenting on vascular recanalization in patients with acute ischemic stroke and the observation of postoperative restenosis. Methods Forty-one patients with acute ischemic stroke in Zhuhai People's Hospital from January 2021 to December 2022 were retrospectively included and divided into control group (21 cases) and observation group (20 cases). Carotid artery stenting and conventional treatment were applied to the control group, and the observation group was treated with butylphthalide and sodium chloride injection before surgery on the basis of the control group. Modified thrombolysis in cerebral infarction (mTICI) grade was used to evaluate vascular recanalization. The mTICI grade 2b or grade 3 indicated successful vascular recanalization, and the mTICI grade 3 indicated complete vascular recanalization. Postoperative mTICI grade was compared between the two groups. The number of cases of restenosis detected by carotid color ultrasound or cerebral angiography 3-6 months after operation in the two groups were counted. Results In the control group, there were 21 patients with postoperative mTICI grade 3. In the observation group, there were 1 patients with postoperative mTICI grade 2b and 19 patients with postoperative mTICI grade 3. Postoperative vascular recanalization was successful in both groups. But there was no significant difference between the two groups (P>0.05). A total of 22 patients in both groups returned to the hospital for re-examination 3-6 months after CAS surgery. The number of restenosis cases was 3 (23.08%) in the control group and 1 (11.11%) in the observation group, and there was no significant difference between the two groups (P>0.05). Conclusions Butylphthalide therapy, which began before carotid artery stenting, had no significant effect on vascular recanalization (mTICI grade) and post-operative restenosis in patients with acute ischemic stroke.

导出引用

曹灿, 杨建豪, 王睿琪, 程光森, 刘羽, 李忠亮, 李晓芬, 方秦, 罗玉鸿, 宋梦姣. 丁苯酞联合颈动脉支架置入术对急性缺血性卒中患者血管再通的研究及术后再狭窄的观察[J]. 中国医药指南. 2025, 23(12): 6-9 https://doi.org/10.15912/j.issn.1671-8194.2025.12.002

CAO Can, YANG Jianhao, WANG Ruiqi, CHENG Guangsen, LIU Yu, LI Zhongliang, LI Xiaofen, FANG Qin, LUO Yuhong, SONG Mengjiao. The Study of Vascular Recanalization and the Observation of Postoperative Restenosis in Patients with Acute Ischemic Stroke by Butylphthalide Combined with Carotid Artery Stenting[J]. Guide of China Medicine. 2025, 23(12): 6-9 https://doi.org/10.15912/j.issn.1671-8194.2025.12.002

中图分类号： R743.3

参考文献

[1] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性卒中诊治指南2023[J]. 中华神经科杂志,2024,57(6):523-559.
[2] 陈大伟,石进. 颈动脉狭窄的脑卒中风险评估现状和思考[J]. 中华老年心脑血管病杂志,2022,24(6):561-563.
[3] 中华医学会外科学分会血管外科学组. 颈动脉狭窄诊治指南[J]. 中国血管外科杂志(电子版),2017,9(3):169-175.
[4] Wang H,Ye K,Li D,et al.DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials[J]. Front Pharmacol, 2022,2(13):963118.
[5] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国缺血性卒中和短暂性脑缺血发作二级预防指南2022[J]. 中华神经科杂志,2022,55(10):1071-1110.
[6] 张妤,王迎. 丁苯酞治疗急性缺血性脑卒中患者血管再通后灌注损伤效果[J]. 深圳中西医结合杂志,2022,32(24):98-101.
[7] 周义锋,刘燕,罗庆明,等. mTICI 2b级与3级再灌注对急性缺血性脑卒中患者远期预后的影响[J]. 中国实用神经疾病杂志,2022,25(7):819-824.
[8] Pilato F,Silva S,Valente I, et al.Predicting Factors of Functional Outcome in Patients with Acute Ischemic Stroke Admitted to Neuro-Intensive Care Unit-A Prospective Cohort Study[J]. Brain Sci,2020,10(12):911.
[9] 张静,马慧杰,张熙雅,等. 丁苯酞对脑缺血再灌注损伤保护作用机制的研究进展[J]. 医药论坛杂志,2021,42(7):136-139.
[10] Wu MY,Yiang GT,Liao WT,et al.Current Mechanistic Concepts in Ischemia and Reperfusion Injury[J]. Cell Physiol Biochem,2018,46(4):1650-1667.
[11] 邓桂芳. 丁苯酞氯化钠注射液治疗缺血性脑卒中的效果分析[J]. 中国实用医药,2024,19(20):126-128.
[12] 谭宇筠,严美庭,孙育伦. 丁苯酞软胶囊治疗急性和慢性缺血性脑卒中疗效的研究[J].黑龙江医药,2023,36(6):1259-1262.
[13] 王淑萍,王树鹏,黄同伟,等. 超微血管成像评价丁苯酞对颈动脉斑块内新生血管的影响[J]. 齐齐哈尔医学院学报,2023,44(21):2044-2047.
[14] 张烁,郭延林,肖贺. 丁苯酞软胶囊治疗颈动脉粥样硬化患者作用分析[J]. 中外医疗,2024,43(11):5-8.
[15] 杨娇,王琼芝,李秋云. 丁苯酞序贯疗法联合双联抗血小板治疗脑梗死合并颈动脉粥样硬化短中期疗效观察[J]. 中国药业,2023,32(23):107-110.
[16] Gerber JC,Miaux YJ,von Kummer R. Scoring flow restoration in cerebral angiograms after endovascular revascularization in acute ischemic stroke patients[J]. Neuroradiology,2015,57(3):227-240.
[17] 唐瑜挺,孙非凡,董凌嘉,等. 颈动脉支架内再狭窄的研究进展[J]. 中国脑血管病杂志,2024,21(10):708-713.
[18] 潘立燕,程淼,李亚侃,等. 通心络胶囊结合丁苯酞治疗对颈动脉支架植入术后再狭窄及血流动力学的影响[J].天津中医药大学学报,2024,43(11):966-970.
[19] Yin W,Lan L,Huang Z,et al.Discovery of a ring-opened derivative of 3-n-butylphthalide bearing NO/H2S-donating moieties as a potential anti-ischemic stroke agent[J]. Eur J Med Chem,2016,115:369-380.